Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB...
AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose...
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE...
AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB...
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF...
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN...
AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science COMMUNIQUE DE PRESSE AB SCIENCE...
AB Science: Revenues for the first half of 2024 and update on AB Science’s activities PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL...
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS...
AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros COMMUNIQUE DE PRESSE AB...
AB Science announces a slight delay in the publication of its 2024 half-year financial report PRESS RELEASE AB SCIENCE ANNOUNCES A SLIGHT DELAY IN...
AB Science annonce un léger décalage de la publication de son rapport financier du premier semestre 2024 COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE...
PRESS RELEASE AB SCIENCE ANNOUNCES A SLIGHT DELAY IN THE PUBLICATION OF ITS 2024 HALF-YEAR FINANCIAL REPORT THE...
AB Science annonce une augmentation de capital de 5,0 millions d’euros COMMUNIQUE DE PRESSE REALISATION AVEC SUCCES D’UNE AUGMENTATION DE CAPITAL...
AB Science provides an update on the microtubule program AB8939 and in particular the ability of AB8939 to generate response on MECOM...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관